Psychiatry & Neurology Doctors in Newburyport, MA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Dr. David W. Green, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 143 State St, Newburyport, MA 01950 Phone: 978-462-2890    Fax: 978-462-2890

Dr. Daniel J. Carlat, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 42 Pleasant St, Newburyport, MA 01950 Phone: 978-499-2277    Fax: 978-499-2201

Michael R Tranfaglia, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 45 Pleasant St, Newburyport, MA 01950 Phone: 978-462-1866

Alexander Lipin, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave., Anna Jaques Hospital, Newburyport, MA 01950 Phone: 978-463-1066    Fax: 978-463-1217

News Archive

AARP Pennsylvania applauds U.S. Senate for protecting seniors' access to their doctors

AARP Pennsylvania State Director Dick Chevrefils today released a statement applauding the U.S. Senate for passing legislation that will preserve access to doctors for people in Medicare by stopping a scheduled 25 percent cut in reimbursement.

Quitting cannabis may not alleviate psychosis

The amount of cannabis used does not appear to be associated with the severity of symptoms in patients with established psychosis, although the drug is linked to a small effect on psychosocial functioning, say UK scientists.

G8 leaders launch $20 billion initiative to help farmers in developing countries

The Washington Post reports: "Leaders of the world's major economies pledged Friday to raise $20 billion over the next three years for food and agricultural aid to the world's most impoverished countries."

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

Read more Medical News

› Verified 3 days ago